Accès gratuit
Numéro
Ann. Fr. Med. Urgence
Volume 5, Numéro 6, Décembre 2015
Page(s) 320 - 328
Section Mise Au Point / Update
DOI https://doi.org/10.1007/s13341-015-0583-y
Publié en ligne 25 novembre 2015
  • Go AS, Mozaffarian D, Roger VL, et al (2013) Heart Disease and Stroke Statistics- 2013 Update: a report from the American Heart Association. Circulation 127:e6–e245 [CrossRef] [PubMed] [Google Scholar]
  • Lev EI, Battler A, Behar S, et al (2003) Frequency, characteristics, and outcome of patients hospitalized with acute coronary syndromes with undetermined electrocardiographic patterns. Am J Cardiol 91:224–7 [CrossRef] [PubMed] [Google Scholar]
  • Amsterdam EA, Wenger NK, Brindis RG, et al (2014) AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes. a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 64:e139–e228 [CrossRef] [PubMed] [Google Scholar]
  • Roffi M, Patrono C, Collet JP, et al (2015) 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J [in press] [Google Scholar]
  • Taboulet P (2011) Syndrome coronaire aigu et ECG : les équivalents ST+. Ann Fr Med Urgence 1:408–14 [CrossRef] [Google Scholar]
  • Lyon R, Morris AC, Caesar D, et al (2007) Chest pain presenting to the emergency department--to stratify risk with GRACE or TIMI? Resuscitation 74:90–3 [CrossRef] [PubMed] [Google Scholar]
  • Savonitto S, Ardissino D, Granger CB, et al (1999) Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA 281:707–13 [CrossRef] [PubMed] [Google Scholar]
  • Newby LK, Jesse RL, Babb JD, et al (2012) ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 60:2427–63 [CrossRef] [PubMed] [Google Scholar]
  • Reichlin T, Hochholzer W, Bassetti S, et al (2009) Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 361:858–67 [CrossRef] [PubMed] [Google Scholar]
  • Thygesen K, Alpert JS, Jaffe AS, et al (2012) Third universal definition of myocardial infarction. J Am Coll Cardiol 60:1581–98 [CrossRef] [PubMed] [Google Scholar]
  • Fesmire FM, Decker WW, Diercks DB, et al from the American College of Emergency Physicians Clinical Policies Subcommittee (Writing Committee) on Non-ST-Segment Elevation Acute Coronary Syndromes (2006) Clinical policy: critical issues in the evaluation and management of adult patients with non-ST-segment elevation acute coronary syndromes. Ann Emerg Med 48:270–301 [CrossRef] [PubMed] [Google Scholar]
  • Charpentier S, Dehours E, Pereira A, et al (2012) Stratification du risque des syndromes coronaires aigus (ST+ et non ST+). In: Textes du 6e Congrès de la Société Française de Médecine Urgence SFMU Paris 2012. http://www.sfmu.org/upload/70_formation/02_eformation/02_congres/Urgences/urgences2012/donnees/fs_tout_auteurs.htm (dernier accès le 2 septembre 2015) [Google Scholar]
  • Montalescot G, Wiviott SD, Braunwald E, et al (2009) Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double blind, randomised controlled trial. Lancet 373:723–31 [CrossRef] [PubMed] [Google Scholar]
  • Wallentin L, Becker RC, Budaj A, et al (2010) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. The PLATelet inhibition and patient Outcomes (PLATO) trial. N Engl J Med 361:1045–57 [CrossRef] [PubMed] [Google Scholar]
  • Montalescot G, Bolognese L, Dudek D, et al (2013) Pretreatment with Prasugrel in Non-ST-Segment Elevation Acute Coronary Syndromes. N Engl J Med 369:999–1010 [CrossRef] [PubMed] [Google Scholar]
  • Bellemain-Appaix A, Kerneis M, O’Connor SA, et al for the ACTION Study Group (2014) Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis. BMJ 349:g6269 [CrossRef] [PubMed] [Google Scholar]
  • Thiele H, Zeymer U, Neumann FJ, et al (2013) Intra-aortic balloon counterpulsation in acute myocardial infarction complicated cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 382:1638–45 [CrossRef] [PubMed] [Google Scholar]
  • Granger CB, Goldberg RJ, Dabbous O, et al (2003) Predictors of hospital mortality in the Global Registry of Acute Coronary Events. Arch Intern Med 163:2345–53 [CrossRef] [PubMed] [Google Scholar]
  • Antmann EM, Cohen M, Bernink PJ, et al (2000) The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision-making. JAMA 284:835–42 [CrossRef] [PubMed] [Google Scholar]
  • Mehta SR, Granger CB, Boden WE, et al (2009) Early versus delayed invasive intervention in acute coronary syndromes. N Engl J Med 360:2165–75 [CrossRef] [PubMed] [Google Scholar]
  • Subherwal S, Bach RG, Chen AY, et al (2009) Baseline Risk of Major Bleeding in Non-ST-Segment-Elevation Myocardial Infarction: The CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA guidelines) Bleeding Score. Circulation 119:1873–82 [CrossRef] [PubMed] [Google Scholar]
  • Ariza-Solé A, Sánchez-Salado JC, Lorente V, et al (2014) Is it possible to separate ischemic and bleeding risk in patients with non-ST segment elevation acute coronary syndromes? Int J Cardiol 171:448–50 [CrossRef] [PubMed] [Google Scholar]
  • Kontos MC, Diercks DB, Ho PM, et al (2011) Treatment and outcomes in patients with myocardial infarction treated with acute beta-blocker therapy: results from the American College of Cardiology’s NCDR®. Am Heart J 161:864–70 [CrossRef] [PubMed] [Google Scholar]
  • Iakobishvili Z, Cohen E, Garty M, et al (2011) Use of intravenous morphine for acute decompensated heart failure in patients with and without acute coronary syndromes. Acute Card Care 13:76–80 [CrossRef] [PubMed] [Google Scholar]
  • Meine TJ, Roe MT, Chen AY, et al (2005) Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. Am Heart J 149:1043–9 [CrossRef] [PubMed] [Google Scholar]
  • Shahzad A, Kemp I, Mars C, et al (2014) Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial. Lancet 384:1849–58 [CrossRef] [PubMed] [Google Scholar]
  • Ohman J, Kudira R, Albinsson S, et al (2012) Ticagrelor induces adenosine triphosphate release from human red blood cells. Biochem Biophys Res Commun 418:754–8 [CrossRef] [PubMed] [Google Scholar]
  • Bhatt DL, Stone GW, Mahaffey KW, et al (2013) Effect of platelet inhibition with cangrelor during PCI on ischemic events. N Engl J Med 368:1303–13 [CrossRef] [PubMed] [Google Scholar]
  • Danchin N, Cucherat M, Thuillez C, et al (2006) Angiotensin-converting enzyme inhibitors in patients with coronary artery disease and absence of heart failure or left ventricular systolic dysfunction: an overview of long-term randomized controlled trials. Arch Intern Med 166:787–96 [CrossRef] [PubMed] [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.